...Student/ MAN3554 Author Note Onlinecci.com; Everest.edu; Abstract Abstract According to a case study conducted by the US Department of Defense, “Tylenol was the most successful over-the-counter product in the United States. There were over 100 million users of the product. Tylenol, outselling 4 other leading painkillers, was responsible for 19% of Johnson & Johnson’s corporate profits during the first 3 quarters of 1982”, which is the very year that they almost lost its reputable view and success over a senseless act that left 6 adults and 1 12-year-old child dead of cyanide poisoning after all had taken capsules of Extra strength Tylenol, a well-known and used over-the-counter medication taken for minor headaches and pain associated with the common cold and other minor symptoms. This is the examination of the way Johnson and Johnson handled this incident that brought about a change and a revolution in the pharmaceutical industry. Keywords: Recall; Tylenol; murders; 1982; tamper The “Tylenol Murders “: The Devastating Recall That Started a Revolution within the Pharmaceutical Industry In the fall of 1982, Johnson and Johnson, the parent company of McNeil Consumer Products Company, which manufactures Tylenol, had to recall its Tylenol Extra Strength capsules, after an investigation into the cyanide- poisoning deaths of 6 adults and one 12-year-old child, occurring in nearly the same time frame and same vicinity, proved that it was from the Tylenol that all the victims...
Words: 1414 - Pages: 6
...get consumers and create a solid revenue stream. We are not just another developer of an insulin pump. Our unique focus of creating an insulin pump that is more manageable for diabetics will give us an advantage over our competitors. We will fund development of our own pod by providing consulting services to create other insulin pumps for diabetics for corporations who are looking to create their own pod-like insulin pump system. These consulting assignments will come from advertising sponsorship relationships that we will establish with companies who are interested in embedding their brand and offers along with our pumps. 2.0 Situation Analysis The Animas Corporation is member of the Johnson and Johnson family of companies (Animas Corporation, 2007-2010). Johnson and Johnson have been around for over 125 years. Currently, Animas Corporation produces an insulin pump for diabetics called the One Touch® Ping™ (Animas Corporation, 2007-2010) (National Diabetes Information Clearinghouse, 2011). In a society where diabetes is increasing, the need for insulin pumps is growing. There are currently 18.8 million people diagnosed and 7.0 million undiagnosed, and the numbers are increasing (National Diabetes Information Clearinghouse, 2011). As of today, there are only five choices for diabetics to choose from when selecting an insulin pump (NA, 2011). With such limited choices, no one company is suffering from hardship, however, new and more innovative models are being manufactured...
Words: 2533 - Pages: 11
...Johnson & Johnson’s Quality Catastrophe Individual Case Study Analysis Johnson & Johnson is a multinational medical devices, pharmaceutical, and consumers packaged goods manufacturer founded in 1886. Until 2005, this corporation ranked at the top of Harris Interactive National Corporate Reputation survey, and was also ranked as the world’s most respected corporation by Barron’s Magazine. This global corporation is made up of 250 subsidiary companies with operations in over 57 countries and products sold in over 174 countries. Due to product recalls, fines for pharmaceutical marketing practices, litigation with shareholders, and other legal issues, Johnson & Johnson’s reputation has been adversely affected in recent years. SWOT Analysis Strengths Johnsons & Johnson is a corporation that has achieved economies of scale and scope. It has a strong global presence represented by over 250 subsidiary companies operating all over the globe. Overall, it has an excellent product portfolio and high quality offerings that satisfies consumer needs on a daily basis. This corporation has placed a huge emphasis on establishing a strong customer base, with recognition for brand loyalty and image. Johnson & Johnson has been a leader in pharmaceuticals and medical devices, which accounts for almost 80% of the corporation’s total revenues. One of its major strengths is the importance of the pharmaceutical and medical advances the company has contributed to society. Some...
Words: 2469 - Pages: 10
...FORTUNE -- It was a humiliating moment. Congressman Edolphus Towns was upbraiding a top Johnson & Johnson executive. Certainly Towns (D-N.Y.), the chairman of the House Committee on Oversight and Government Reform, has browbeaten his share of CEOs and Wall Street titans. But it's not the sort of thing that usually happens to J&J. At this hearing in May, though, Towns laid into the health care giant. "The information I've seen during the course of our investigation raises questions about the integrity of the company," he boomed. "It paints a picture of a company that is deceptive, dishonest, and has risked the health of many of our children." That's a damning indictment for any business, but an especially shocking one for Johnson & Johnson (JNJ, Fortune 500), one of America's most iconic and trusted brands -- the one whose products you give your children. For more than a century J&J has built a sterling reputation as the maker of such products as Band-Aids, Baby Shampoo, and Tylenol. It considers its business a mission -- at least according to its credo, which pledges responsibility first "to the doctors, nurses, and patients, to mothers and fathers and all others who use our products and services." But serious questions have been raised about the quality of numerous J&J products. Since September 2009, McNeil Consumer Healthcare, the J&J division that makes over-the-counter (OTC) drugs, has announced eight recalls, including one for an estimated 136 million...
Words: 3647 - Pages: 15
...ANNUAL REPORt 2011 Johnson & Johnson will continue to bring meaningful innovations to people around the world so they can live better and healthier lives. We are deeply committed and dedicated to the people who use our products, our employees, the communities in which we live and work, and you, our shareholders. Most important, we will never lose sight of who we are. ON tHE COVER Matt Cox, who has type 1 diabetes and uses the waterproof ANIMAS® VIBE™ insulin pump, swam an English Channel relay to raise money for the Juvenile Diabetes Research Foundation. Matt wants to show his son, Jack, who also has type 1 diabetes, that the condition need not hold him back in life. Read Matt’s story on page 16. CHAIRMAN’S LETTER To Our Shareholders hroughout our annual report this year, you’ll read the severe economic decline; the tightening of consumer about how Johnson & Johnson is bringing meaningful spending and health care budgets; over-the-counter (OTC) innovation to our patients and customers, and making product quality issues at McNeil Consumer Healthcare and a difference in their lives in a personal way—from the recall of the DePuy ASR™ Hip System. Brunhilde Wecker, who made a full recovery from her stroke Our company was severely tested. thanks to our new blood clot retrieval and removal device, In managing through this stretch, we relied heavily on the resolve to our own Bill Hait, an oncologist whose vision and insights of our people and on our time-tested business...
Words: 55630 - Pages: 223
...Journal of Academic and Business Ethics c Johnson & Johnson: An ethical analysis of broken trust t Karen L. Stewart The Richard Stockton College of New Jersey Whiton S. Paine The Richard Stockton College of New Jersey ABSTRACT For several decades, Johnson & Johnson has been the exemplar of superb ethical behavior in light of the prompt actions it undertook during the 1982 Tylenol cyanide poisoning incident. Now several decades later, J&J’s Consumer Product Division has put the company and . its reputation in jeopardy by its slow and ineffective response to a series of ongoing problems. ineffective This article provides an ethical analysis of those events and addresses the negative impact on Johnson and Johnson’s once sterling reputation. Business, ethics, recalls, Johnson & Johnson, reputation, FDA J&J: An ethical analysis, Page 1 analysis Journal of Academic and Business Ethics c INTRODUCTION: For several decades, Johnson & Johnson has been the exemplar of superb ethical behavior in light of the prompt actions it undertook during the 1982 Tylenol cyanide poisoning incident that left seven dead in the Chicago area. After the 1982 incident, Tylenol quickly even returned to category dominance. A few years later when yet another cyanide-laced Tylenol laced capsule resulted in the death of a New York woman, Johnson & Johnson and its McNeil subsidiary once again took quick action by only making a compressed and easier-to-detectnce easier tampering...
Words: 6273 - Pages: 26
...the early years Tylenol was developed by McNeil Laboratories. It has as its active ingredient a generic compound that can be manufactured by most pharmaceutical companies: acetaminophen. After Johnson & Johnson acquired McNeil in 1959, it began aggressively to advertise the product—to health professionals—as an analgesic that was as effective as aspirin but easier on the stomach. By 1970, sales of Tylenol were growing about 20 to 30 percent annually, with projected sales to reach about $60 million by 1975. With the release of a number of studies in the early 1970s which questioned the wisdom of widespread dependency on aspirin as a pain-killer, the use of acetaminophen accelerated with Tylenol accounting for 90 percent of acetaminophen sales. Two-thirds of Tylenol users were introduced to the product by physicians. Others became familiar with it through hospitals, where it was used extensively—not necessarily because it was the medication of choice, but because it was generally less expensive than other analgesics and less interactive than aspirin. When a 1976 survey showed that consumers were generally aware that Tylenol was easier on their digestive system than other analgesics but felt that this benefit was achieved at a loss of efficacy to reduce pain, Johnson & Johnson introduced Extra-Strength Tylenol. Extra-Strength Tylenol became the first nonprescription analgesic to contain 500 mg of pain-killer per unit—the established industry dosage was 325 mg for regular...
Words: 2190 - Pages: 9
...BUSINESS DECISION MAKING INTRODUCTION Johnson and Johnson is an American multinational company founded in Brunswick ,New Jersey in 1886 by American entrepreneur Robert Wood Johnson. It manufactures pharmaceuticals, medical devices and consumer products. J&J and its subsidiaries have operations in over 60 countries and sell their products in over 175 countries. Today, it employs 120,000 people worldwide. They are the world’s second largest manufacturer of health care products and the largest developer and manufacturer of medical treatment and diagnostic devices. Is the second revenue earner for the company, focuses on medical needs in cardiovascular, metabolism, immunology and oncology Medical Devices and Diagnostics Is actually the smallest division but include some of them most well know products Prescription Products Consumer Products EXECUTIVE SUMMARY Is the largest segment producing medical equipment, surgical systems and devices LISTERINE, NEOSPORIN, NEUTROGENA, SPLENDA, BAND-AIDS, TYLENOL,VISINE, ACUVUE, ONETOUCH, JOHNSON'S BABY PRODUCTS (LOTION, SOAP, SHAMPOO) COMPETITIVE ADVANTAGE Strong branding and customer loyalty Patient protection Diversification in research and development of new products A single focused business segment in healthcare Company structure / Management approach EXTERNAL & INTERNAL ENVIRONMENTS Consumer bargaining power Threat of entry Threat of substitutes Competition...
Words: 1058 - Pages: 5
...BUSINESS DECISION MAKING INTRODUCTION Johnson and Johnson is an American multinational company founded in Brunswick ,New Jersey in 1886 by American entrepreneur Robert Wood Johnson. It manufactures pharmaceuticals, medical devices and consumer products. J&J and its subsidiaries have operations in over 60 countries and sell their products in over 175 countries. Today, it employs 120,000 people worldwide. They are the world’s second largest manufacturer of health care products and the largest developer and manufacturer of medical treatment and diagnostic devices. EXECUTIVE SUMMARY Consumer Products Prescription Products Medical Devices and Diagnostics Is actually the smallest division but include some of them most well know products Is the second revenue earner for the company, focuses on medical needs in cardiovascular, metabolism, immunology and oncology Is the largest segment producing medical equipment, surgical systems and devices LISTERINE, NEOSPORIN, NEUTROGENA, SPLENDA, BAND-AIDS, TYLENOL,VISINE, ACUVUE, ONETOUCH, JOHNSON'S BABY PRODUCTS (LOTION, SOAP, SHAMPOO) COMPETITIVE ADVANTAGE Strong branding and customer loyalty Patient protection Diversification in research and development of new products A single focused business segment in healthcare Company structure / Management approach EXTERNAL & INTERNAL ENVIRONMENTS Consumer bargaining power Threat of entry Threat of substitutes Competition / Rivalry • The largest risk is the...
Words: 1058 - Pages: 5
...Tylenol Ethics Paper MGT/498 Tylenol Ethics Paper Johnson & Johnson companies reside in over 57 countries all across the world. This company consists of 250 sister companies. “Our Family of Companies is organized into several business segments comprised of franchises and therapeutic categories (Johnson & Johnson Services, Inc., 2013)”. Johnson & Johnson is broke up into three main segments which include healthcare consumer, pharmaceuticals, and medical device and diagnostics. During 1982 Johnson & Johnson accidently “replaced Tylenol Extra-Strength capsules with cyanide-laced capsules, resealed the packages, and deposited them on the shelves of at least a half-dozen or so pharmacies and food stores in the Chicago area. The poison capsules were purchased, and seven unsuspecting people died a horrible death. Johnson & Johnson, parent company of McNeil Consumer Products Company which makes Tylenol, suddenly, and with no warning, had to explain to the world why its trusted product was suddenly killing people (Johnson & Johnson Services, Inc., 2013)”. Johnson & Johnson was informed of this mistake by a Chicago news reporter. The news reporter told Johnson & Johnson that the medical examiner in Chicago “had just given a press conference people were dying from poisoned Tylenol (Johnson & Johnson Services, Inc., 2013)”. Johnson & Johnson remedially formed a seven-member strategy team to figure out how they...
Words: 671 - Pages: 3
...1. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey and it’s industry is Drug Manufacturers. Johnson & Johnson along with its subsidiaries, researches, develops, manufactures and sells various products in the health care field worldwide. It operates in three different segments which are consumer, pharmaceutical and medical devices. The consumer segment offers baby care products under the Johnson S brand name; Oral care products which is under the Listerine brand name; Skin products under the Aveeno, Clean & Clear, Dabao, Johnson S Adult, Le Petite Marseillais, Lubriderm, Neutrogena, and RoC brand names; Women’s health product like the sanitary pads under the Stayfree and Carefree, and o.b. tampon brand names; wound care products which includes adhesive bandages and first aid products under the Band-Aid and Neosporin brand anmes; and nutritional products which comprises of no calorie sweetener under the Splenda brand name. This segment also offers over the counter medicines which includes acetaminophen products under the Tylenol brand name; cold, flue, and allergy products under the Sudafed brand name. Also allergy products under under the Benadryl and Zyrtec brand names are included; ibuprofen products under the Motrin IB brand name; and heartburn products under the Repcid brand name. In the Pharmaceutical segment, it provides various products in the areas of immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic...
Words: 702 - Pages: 3
...Johnson & Johnson Over the years Johnson & Johnson has grown substantially due to strategic acquisitions expanding in a wide range of product lines such as Neutrogena in 1994, DePuy in 1998 and Pfizer in 2006. Currently holding over 250 different businesses separated into three divisions: Pharmaceuticals, Medical Devices & Diagnostics, and Consumer products. Historically such divisions have thrived through the decentralized, entrepreneurship culture (Dess, Lumpkin, Eisner, & McNamara, 2014). Nonetheless, impediments such as numerous product recalls, detrimental litigations has now placed Johnson and Johnson’s reputation in jeopardy. Subsidiary McNeil Consumer Healthcare has had a long history of product recalls, mostly know for the biggest children’s drug recall however coming out with little impact on the corporate reputation. Strong company ethical behaviour was the key to the smooth mergence. Johnson & Johnson showed them prepared to bear the short-term cost in the name of consumer safety. Strongly establishing a basis for trust within customers. On the other hand DePuy’s Orthopaedics unit hip replacement recall, has left not only over 10,000 lawsuits in the US, but has tarnished the name of such a trusted brand (Dess et al, 2014). Incubuses a slow ineffective response to series of problems that predominant in poor quality control inside some of the manufacturing plants. An unsuccessful corrective action plan needed to counter consumers‘ complaints and growing...
Words: 503 - Pages: 3
...Johnson and Johnson Supply Chain Case Analysis Table of Contents I. Executive Summary…………………………………….3 II. Backgound / History……………………………………4 III. Supply Chain Analysis…………………………………5 IV. Recommendations………………………………………7 V. Work Cited………………………………………………8 I. Executive Summary Johnson and Johnson is a medical devices, pharmaceutical and consumer packaged goods manufacture founded in 1886. They are U.S. multinational company, who is listed among the Fortune 500. Johnson and Johnson Credo is a statement of their values and responsibilities that was written over 60 years ago. It articulates their responsibilities to customers, employees, communities and shareholders. There philosophy and core values are centered and desired to provide the safest and most reliable products and services to their customers. Johnson and Johnson offer’s a diverse business. A business that is a leader and offers many medical devices, pharmaceutical and consumer packaged goods that dominate over their competitor’s. There forecast show’s growth despite them facing challenges. They have successfully employed strategies to differentiate themselves that helps them distinguish themselves from its competitors. Johnson and Johnson does not have control over external supply chain, but are committed to ensure operations on their behalf are consistent with their values. With an annual spending being about $30 billion, they are able to leverage their purchasing power and set expectation...
Words: 1300 - Pages: 6
...PROPOSAL OUTLINE Annette M Daniels 1. THE PAINFUL TRUTH OF A COMPANY’S PURSUIT OF QUALITY 2. Johnson and Johnson 3. Johnson & Johnson was organized in the State of New Jersey in 1886. Today they employee approximately 115,000 people worldwide. Johnson & Johnson has more than 250 companies located in 57 countries around the world. From these 250 companies they Manufacture and sell health care products. The Family of Companies is organized into several business segments comprised of franchises and therapeutic categories. * Consumer Health Care The Consumer segment includes a broad range of consumer health and personal care products in the beauty, baby, oral care and women’s health categories, as well as nutritional products and over-the-counter medicines and wellness and prevention platforms. * Medical Devices & Diagnostics The Medical Devices & Diagnostics segment focuses on technologies, solutions and services in the fields of cardiovascular disease, diabetes care, orthopedics, vision care, wound care, aesthetics, sports medicine, infection prevention, minimally invasive surgery, and diagnostics. * Pharmaceuticals It includes products in the anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, and urology and virology fields. * Many of Johnson and Johnson’s businesses and facilities have been certified to meet International Organization for...
Words: 976 - Pages: 4
...Paper Johnson and Johnson (JNJ) began in the late 1880s as a family owned and operated business geared toward the health care and first aid of individuals. In their first 20 years of operation, Johnson and Johnson built a solid domestic business and were among the first responders to the 1906 San Francisco Earthquake. Currently, Johnson and Johnson span the globe with more than 250 locations in 57 countries ("Johnson and Johnson Company Structure", 2011). In JNJ’s century plus experience and business operations, adjusting and adapting the functions of management to meet operational goals and public demands is a testament to their longevity. From their worldwide expansion, innovations in healthcare, business ethics, contributions to technology, to their community diversity, JNJ provides a “How to Succeed in Business” guide for others to follow. Internal and external factors involved in technology affect management’s efficiency in planning, organizing, leading and controlling. The new advances in technology have provided new production techniques and new ways to manage and communicate such as telecommuting and robotic manufacturing. The technology of computers has increased productivity and performance. Management is able to watch and learn what the competitors are doing and improve the efficiency in decision making. There are also threats involved with technology when ensuring the most up to date technology and developments are used. Johnson and Johnson’s...
Words: 286 - Pages: 2
